These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 19922883)

  • 1. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.
    Senneville E; Legout L; Valette M; Yazdanpanah Y; Giraud F; Beltrand E; Obert G; Dubreuil L; Migaud H; Mouton Y
    J Antimicrob Chemother; 2004 Oct; 54(4):798-802. PubMed ID: 15329363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
    Wu VC; Wang YT; Wang CY; Tsai IJ; Wu KD; Hwang JJ; Hsueh PR
    Clin Infect Dis; 2006 Jan; 42(1):66-72. PubMed ID: 16323094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
    Lin YH; Wu VC; Tsai IJ; Ho YL; Hwang JJ; Tsau YK; Wu CY; Wu KD; Hsueh PR
    Int J Antimicrob Agents; 2006 Oct; 28(4):345-51. PubMed ID: 16935472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
    Patel N; VanDeWall H; Tristani L; Rivera A; Woo B; Dihmess A; Li HK; Smith R; Lodise TP
    J Antimicrob Chemother; 2012 Mar; 67(3):727-35. PubMed ID: 22174041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic effects of linezolid in young children.
    Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia associated with linezolid therapy.
    Attassi K; Hershberger E; Alam R; Zervos MJ
    Clin Infect Dis; 2002 Mar; 34(5):695-8. PubMed ID: 11803505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
    Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients.
    Hirano R; Sakamoto Y; Tachibana N; Ohnishi M
    Int J Clin Pharm; 2014 Aug; 36(4):795-9. PubMed ID: 24913359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid-associated thrombocytopenia.
    Lam S
    Consult Pharm; 2012 Jul; 27(7):504-8. PubMed ID: 22910131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
    Cohen N; Mihu CN; Seo SK; Chung D; Chou J; Heller G; Papanicolaou GA
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1337-41. PubMed ID: 19747643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
    Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight.
    Niwa T; Watanabe T; Suzuki A; Ohmori T; Tsuchiya M; Suzuki T; Ohta H; Murakami N; Itoh Y
    Diagn Microbiol Infect Dis; 2014 May; 79(1):93-7. PubMed ID: 24565849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid-related immune-mediated severe thrombocytopenia.
    Pascoalinho D; Vilas MJ; Coelho L; Moreira P
    Int J Antimicrob Agents; 2011 Jan; 37(1):88-9. PubMed ID: 21075603
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and tolerability of linezolid in children.
    Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy.
    Takahashi Y; Takesue Y; Nakajima K; Ichiki K; Tsuchida T; Tatsumi S; Ishihara M; Ikeuchi H; Uchino M
    J Infect Chemother; 2011 Jun; 17(3):382-7. PubMed ID: 21127934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of linezolid in bone marrow transplantation patients.
    Hogan HL; Hachem RY; Neuhauser M; Raad II; Coyle E
    J Pharm Pract; 2010 Aug; 23(4):352-7. PubMed ID: 21507835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia.
    Grau S; Morales-Molina JA; Mateu-de Antonio J; Marín-Casino M; Alvarez-Lerma F
    J Antimicrob Chemother; 2005 Aug; 56(2):440-1. PubMed ID: 15956097
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.